Sign Up Today and Learn More About Humatics Stock
Invest in or calculate the value of your shares in Humatics or other pre-IPO companies through EquityZen's platform.
Humatics Stock (HUMT)
Microlocation Products
Humatics provides precision location solutions for industry and mobility through microlocation technology
About Humatics Stock
Founded
2015
Headquarters
Waltham, MA, US
Total Funding
88.7M
Industries
Hardware, Software, Science and Engineering
Humatics creates microlocation technology which enables robots to work alongside humans without accidents. The Humatics Spatial Intelligence Platform™ is comprised of the microlocation system and analytics software. Humatics claims that this software will revolutionize how people and machines locate, navigate and collaborate in the connected world.
Humatics was founded in 2015 by David Mindel and Gary Cohen. Humatics is headquartered in in Kendall Square, Cambridge, Massachusetts. Notable investors in Humatics include Blackhorn Ventures, Tenfore Holdings, and Lockheed Martin Ventures.
Humatics Press Mentions
Stay in the know about the latest news on Humatics
Antennas for radio-frequency localization
patents • Oct 27, 2024
Radio-frequency systems and methods for co-localization of multiple devices and …
patents • Oct 27, 2024
Chip-scale radio-frequency localization devices and associated systems and …
patents • Apr 13, 2024
Radio-frequency systems and methods for co-localization of medical devices and …
patents • Apr 13, 2024
Radio-frequency systems and methods for co-localization of multiple devices and …
patents • Apr 13, 2024
Investors in Humatics
Discover investors in Humatics stock and explore their portfolio companies
Humatics Management
Leadership team at Humatics
Chief Executive Officer
Shawn Henry
Chief Financial Officer
Gary Warzynski
Join now and verify your accreditation status to gain access to:
- Humatics current valuation
- Humatics stock price
- Available deals in Humatics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Humatics stock?
Accredited investors can buy pre-IPO stock in companies like Humatics through EquityZen funds. These investments are made available by existing Humatics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Humatics stock?
Shareholders can sell their Humatics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
